‘ICSR’ refers to Individual Case Safety Reports which must be compiled for each instance of a suspected or confirmed adverse event and each reception of a report about one to the Competent Authority (CA) of the Member State.
Remaining compliant throughout all the changes to EU legislation can be a challenging endeavour for any company. This is particularly the case with Expedited Reporting – one of the pillars of all EU pharmacovigilance work.
Why Are Correct Screening Procedures So Important?
Periodic safety update reports (PSUR) are required for all products that have marketing authorisation in the EU.
Business-Critical Responses – Your Processing of Safety Signals
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)